Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Home
  2. Azioni
  3. Svizzera
  4. Swiss Exchange
  5. Novartis AG
  6. SocietÓ
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Rapporto
Tempo differito Swiss Exchange  -  17:30:04 03/02/2023
79.54 CHF   +1.64%
03/02Borsa svizzera: chiude in rialzo, SMI +1,44%
AW
03/02Novartis AG: DA Davidson ribadisce il giudizio positivo sul titolo
MM
03/02NOVARTIS AG: JP Morgan conferma il giudizio Neutral
MD
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietÓFinanzaConsensusRevisioniDerivatiFondi 
AttivitÓ
Logo Novartis AG
Novartis AG Ŕ uno dei leader mondiali nella progettazione, produzione e commercializzazione di prodotti farmaceutici. Le vendite nette sono suddivise per famiglia di prodotti come segue:
- prodotti farmaceutici (81,7%): utilizzati per il trattamento di malattie cardiovascolari, respiratorie e dermatologiche, disturbi gastrointestinali, tumori, disturbi del sistema nervoso centrale, squilibri ormonali, eccetera;
- farmaci generici (18,3%; Sandoz).
Le vendite nette sono distribuite geograficamente come segue: Europa (36,5%), Stati Uniti (34,9%), Asia/Africa/Australasia (20,9%), Canada e America Latina (7,7%).

Numero di dipendenti : 101 703 persone.
Vendite per attivitÓ
20212022Delta
Innovative Medicines38 394.6081.3%39 440.4081.7% +2.72%
Sandoz8 805.3018.7%8 833.4018.3% +0.32%
CHF in Milioni
Vendite per regione
20212022Delta
United States15 376.1032.6%16 859.8034.9% +9.65%
Europe10 909.0023.1%10 469.4021.7% -4.03%
Asia/Africa/Australasia4 782.5310.1%4 974.9310.3% +4.02%
Germany4 452.489.4%4 085.778.5% -8.24%
Canada and Latin America3 332.507.1%3 708.527.7% +11.28%
China2 790.345.9%2 987.446.2% +7.06%
France2 305.784.9%2 155.584.5% -6.51%
Japan2 452.985.2%2 105.924.4% -14.15%
Switzerland798.161.7%926.411.9% +16.07%
CHF in Milioni
Dirigenti
Nome Titolo EtÓ Da
Vasant Narasimhan Chief Executive Officer 46 2018
Harry Werner Kirsch Chief Financial Officer 57 2013
Shreeram Aradhye Chief Medical Officer 59 2022
Steffen Lang President-Operations 55 2022
Klaus Moosmayer Chief Ethics, Risk & Compliance Officer 54 2018
Samir Shah, Dr. Global Head-Investor Relations - -
Charlotte Pamer-Wieser, Dr. Secretary - 2011
Elizabeth Theophille Chief Technology Transformation Officer 55 2020
Linda Kanitra Associate Director-Drug Development - -
Marie-France Tschudin Chief Commercial Officer - 2022
Amministratori
Nome Titolo EtÓ Da
J÷rg Reinhardt Non-Executive Chairman 66 2013
Andreas von Planta, Dr. Independent Non-Executive Director 67 2006
Charles L. Sawyers, Dr. Independent Non-Executive Director 63 2013
William Thomas Winters Independent Non-Executive Director 61 2013
Nancy C. Andrews, Dr. Independent Non-Executive Director 64 2015
Mary Elizabeth Doherty Independent Non-Executive Director 65 2016
Ton BŘchner Independent Non-Executive Director 57 2016
Frans Van Houten Independent Non-Executive Director 62 2017
Patrice Bula Lead Independent Director 66 2022
Bridgette P. Heller Director 61 2020
Azioni
Voto QuantitÓFlottanteAutocontrolloFlottante totale
Azione A 1 2 403 721 252 2 092 926 588 87.1% 284 112 195 11.8% 87.1%
Azionisti
NomeAzioni%
Novartis AG 282 034 061 11,7%
Sandoz Family Foundation 89 135 960 3,71%
The Vanguard Group, Inc. 59 872 956 2,49%
UBS Asset Management Switzerland AG 55 730 682 2,32%
Norges Bank Investment Management 50 631 295 2,11%
Credit Suisse Asset Management (Schweiz) AG 50 012 984 2,08%
Wellington Management Co. LLP 48 518 054 2,02%
Novartis Foundation For Employee Participation 47 834 052 1,99%
Dodge & Cox 19 973 770 0,83%
Artisan Partners LP 18 087 944 0,75%
Partecipazioni
NomeAzioni%Valorizzazione
NOVARTIS AG (NOVN) 282 034 061 11,7% 25 481 221 804 USD
NOVARTIS INDIA LIMITED (500672) 17 450 680 70,7% 142 381 320 USD
ERASCA, INC. (ERAS) 12 307 692 8,94% 53 046 153 USD
PLIANT THERAPEUTICS, INC. (PLRX) 2 153 526 4,42% 41 627 658 USD
POSEIDA THERAPEUTICS, INC. (PSTX) 5 908 089 6,87% 31 312 872 USD
SOMALOGIC, INC. (SLGC) 10 422 469 5,56% 26 160 397 USD
MOLECULAR PARTNERS AG (MOLN) 1 739 130 4,82% 11 579 162 USD
SURFACE ONCOLOGY, INC. (SURF) 3 948 482 6,52% 3 237 755 USD
TSCAN THERAPEUTICS, INC. (TCRX) 916 101 4,84% 1 419 957 USD
AYALA PHARMACEUTICALS INC 698 777 4,71% 279 511 USD
Mercati e indici
- Primary listing
- SMI / FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200
Codici di Borsa
- Codice Bloomberg :  
- Codice Reuters :  NOVN.S
- Codice Datastream :  
Coordinate societÓ
Novartis AG
Lichtstrasse 35
CH-4056 Basel, Basel-Stadt

Telefono : +41 61 324 11 11
Fax : +41 61 324 80 01
Internet : http://www.novartis.com
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pi¨ marchi di Novartis AG
Settore Prodotti farmaceutici - Altri
Var. 1genCapi. (M$)
NOVARTIS AG-4.85%182 524
JOHNSON & JOHNSON-6.29%430 370
ELI LILLY AND COMPANY-9.61%322 186
NOVO NORDISK A/S0.37%309 611
ROCHE HOLDING AG-2.81%269 030
MERCK & CO., INC.-7.22%260 994
ABBVIE INC.-10.15%256 696
PFIZER, INC.-13.47%247 323
ASTRAZENECA PLC-5.71%198 277
BRISTOL-MYERS SQUIBB COMPANY1.14%165 253
AMGEN INC.-6.13%130 818
SANOFI-5.23%115 251
GILEAD SCIENCES, INC.-5.20%105 372
GSK PLC0.14%70 256
BAYER AG17.29%60 427
DAIICHI SANKYO CO., LTD.-4.45%59 466
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.46%49 527
CHUGAI PHARMACEUTICAL CO., LTD0.27%42 431
JIANGSU HENGRUI MEDICINE CO., LTD.11.08%40 367
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD5.60%27 175
ASTELLAS PHARMA INC.-5.83%26 304